ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Nuclear Medicine & Radiopharmaceutic Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-0A8912
Home | Market Reports | Business & Industrial| Energy & Utilities
Global Nuclear Medicine Radiopharmaceutic Market Insights and Forecast to 2028
BUY CHAPTERS

Global Nuclear Medicine & Radiopharmaceutic Market Research Report 2025

Code: QYRE-Auto-0A8912
Report
September 2025
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
GE Healthcare
Bracco Imaging
Mallinckrodt plc
Lantheus Medical Imaging
Bayer
Jubilant Pharma
Nordion
Eli Lilly
Siemens AG
China Isotope & Radiation
Yantai Dongcheng Biochemicals
China Isotope & Radiation

Nuclear Medicine & Radiopharmaceutic Market Size

The global market for Nuclear Medicine & Radiopharmaceutic was valued at US$ 8789 million in the year 2024 and is projected to reach a revised size of US$ 15540 million by 2031, growing at a CAGR of 8.6% during the forecast period.

Nuclear Medicine & Radiopharmaceutic Market

Nuclear Medicine & Radiopharmaceutic Market

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Nuclear Medicine & Radiopharmaceutic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Medicine & Radiopharmaceutic.
The Nuclear Medicine & Radiopharmaceutic market size, estimations, and forecasts are provided in terms of sales volume (Kiloton) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nuclear Medicine & Radiopharmaceutic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nuclear Medicine & Radiopharmaceutic manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Nuclear Medicine & Radiopharmaceutic Market Report

Report Metric Details
Report Name Nuclear Medicine & Radiopharmaceutic Market
Accounted market size in year US$ 8789 million
Forecasted market size in 2031 US$ 15540 million
CAGR 8.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Tc-99
  • I-123/131
  • In-111
  • Xe-133
  • Th-201
  • Ga-67
  • Other
Segment by Application
  • Diagnostic
  • Therapeutic
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GE Healthcare, Bracco Imaging, Mallinckrodt, Lantheus Medical Imaging, Bayer, Jubilant Pharma, Nordion, Eli Lilly, SIEMENS, China Isotope & Radiation, Yantai Dongcheng Biochemicals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Nuclear Medicine & Radiopharmaceutic manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Nuclear Medicine & Radiopharmaceutic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Nuclear Medicine & Radiopharmaceutic Market growing?

Ans: The Nuclear Medicine & Radiopharmaceutic Market witnessing a CAGR of 8.6% during the forecast period 2025-2031.

What is the Nuclear Medicine & Radiopharmaceutic Market size in 2031?

Ans: The Nuclear Medicine & Radiopharmaceutic Market size in 2031 will be US$ 15540 million.

Who are the main players in the Nuclear Medicine & Radiopharmaceutic Market report?

Ans: The main players in the Nuclear Medicine & Radiopharmaceutic Market are GE Healthcare, Bracco Imaging, Mallinckrodt, Lantheus Medical Imaging, Bayer, Jubilant Pharma, Nordion, Eli Lilly, SIEMENS, China Isotope & Radiation, Yantai Dongcheng Biochemicals

What are the Application segmentation covered in the Nuclear Medicine & Radiopharmaceutic Market report?

Ans: The Applications covered in the Nuclear Medicine & Radiopharmaceutic Market report are Diagnostic, Therapeutic

What are the Type segmentation covered in the Nuclear Medicine & Radiopharmaceutic Market report?

Ans: The Types covered in the Nuclear Medicine & Radiopharmaceutic Market report are Tc-99, I-123/131, In-111, Xe-133, Th-201, Ga-67, Other

1 Nuclear Medicine & Radiopharmaceutic Market Overview
1.1 Product Definition
1.2 Nuclear Medicine & Radiopharmaceutic by Type
1.2.1 Global Nuclear Medicine & Radiopharmaceutic Market Value Comparison by Type (2024 VS 2031)
1.2.2 Tc-99
1.2.3 I-123/131
1.2.4 In-111
1.2.5 Xe-133
1.2.6 Th-201
1.2.7 Ga-67
1.2.8 Other
1.3 Nuclear Medicine & Radiopharmaceutic by Application
1.3.1 Global Nuclear Medicine & Radiopharmaceutic Market Value by Application (2024 VS 2031)
1.3.2 Diagnostic
1.3.3 Therapeutic
1.4 Global Nuclear Medicine & Radiopharmaceutic Market Size Estimates and Forecasts
1.4.1 Global Nuclear Medicine & Radiopharmaceutic Revenue 2020-2031
1.4.2 Global Nuclear Medicine & Radiopharmaceutic Sales 2020-2031
1.4.3 Global Nuclear Medicine & Radiopharmaceutic Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Nuclear Medicine & Radiopharmaceutic Market Competition by Manufacturers
2.1 Global Nuclear Medicine & Radiopharmaceutic Sales Market Share by Manufacturers (2020-2025)
2.2 Global Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Nuclear Medicine & Radiopharmaceutic Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Nuclear Medicine & Radiopharmaceutic, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Nuclear Medicine & Radiopharmaceutic, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nuclear Medicine & Radiopharmaceutic, Product Type & Application
2.7 Global Key Manufacturers of Nuclear Medicine & Radiopharmaceutic, Date of Enter into This Industry
2.8 Global Nuclear Medicine & Radiopharmaceutic Market Competitive Situation and Trends
2.8.1 Global Nuclear Medicine & Radiopharmaceutic Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Nuclear Medicine & Radiopharmaceutic Players Market Share by Revenue
2.8.3 Global Nuclear Medicine & Radiopharmaceutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Nuclear Medicine & Radiopharmaceutic Market Scenario by Region
3.1 Global Nuclear Medicine & Radiopharmaceutic Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Nuclear Medicine & Radiopharmaceutic Sales by Region: 2020-2031
3.2.1 Global Nuclear Medicine & Radiopharmaceutic Sales by Region: 2020-2025
3.2.2 Global Nuclear Medicine & Radiopharmaceutic Sales by Region: 2026-2031
3.3 Global Nuclear Medicine & Radiopharmaceutic Revenue by Region: 2020-2031
3.3.1 Global Nuclear Medicine & Radiopharmaceutic Revenue by Region: 2020-2025
3.3.2 Global Nuclear Medicine & Radiopharmaceutic Revenue by Region: 2026-2031
3.4 North America Nuclear Medicine & Radiopharmaceutic Market Facts & Figures by Country
3.4.1 North America Nuclear Medicine & Radiopharmaceutic Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Nuclear Medicine & Radiopharmaceutic Sales by Country (2020-2031)
3.4.3 North America Nuclear Medicine & Radiopharmaceutic Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Nuclear Medicine & Radiopharmaceutic Market Facts & Figures by Country
3.5.1 Europe Nuclear Medicine & Radiopharmaceutic Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Nuclear Medicine & Radiopharmaceutic Sales by Country (2020-2031)
3.5.3 Europe Nuclear Medicine & Radiopharmaceutic Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nuclear Medicine & Radiopharmaceutic Market Facts & Figures by Region
3.6.1 Asia Pacific Nuclear Medicine & Radiopharmaceutic Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Nuclear Medicine & Radiopharmaceutic Sales by Region (2020-2031)
3.6.3 Asia Pacific Nuclear Medicine & Radiopharmaceutic Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Nuclear Medicine & Radiopharmaceutic Market Facts & Figures by Country
3.7.1 Latin America Nuclear Medicine & Radiopharmaceutic Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Nuclear Medicine & Radiopharmaceutic Sales by Country (2020-2031)
3.7.3 Latin America Nuclear Medicine & Radiopharmaceutic Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nuclear Medicine & Radiopharmaceutic Market Facts & Figures by Country
3.8.1 Middle East and Africa Nuclear Medicine & Radiopharmaceutic Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Nuclear Medicine & Radiopharmaceutic Sales by Country (2020-2031)
3.8.3 Middle East and Africa Nuclear Medicine & Radiopharmaceutic Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nuclear Medicine & Radiopharmaceutic Sales by Type (2020-2031)
4.1.1 Global Nuclear Medicine & Radiopharmaceutic Sales by Type (2020-2025)
4.1.2 Global Nuclear Medicine & Radiopharmaceutic Sales by Type (2026-2031)
4.1.3 Global Nuclear Medicine & Radiopharmaceutic Sales Market Share by Type (2020-2031)
4.2 Global Nuclear Medicine & Radiopharmaceutic Revenue by Type (2020-2031)
4.2.1 Global Nuclear Medicine & Radiopharmaceutic Revenue by Type (2020-2025)
4.2.2 Global Nuclear Medicine & Radiopharmaceutic Revenue by Type (2026-2031)
4.2.3 Global Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Type (2020-2031)
4.3 Global Nuclear Medicine & Radiopharmaceutic Price by Type (2020-2031)
5 Segment by Application
5.1 Global Nuclear Medicine & Radiopharmaceutic Sales by Application (2020-2031)
5.1.1 Global Nuclear Medicine & Radiopharmaceutic Sales by Application (2020-2025)
5.1.2 Global Nuclear Medicine & Radiopharmaceutic Sales by Application (2026-2031)
5.1.3 Global Nuclear Medicine & Radiopharmaceutic Sales Market Share by Application (2020-2031)
5.2 Global Nuclear Medicine & Radiopharmaceutic Revenue by Application (2020-2031)
5.2.1 Global Nuclear Medicine & Radiopharmaceutic Revenue by Application (2020-2025)
5.2.2 Global Nuclear Medicine & Radiopharmaceutic Revenue by Application (2026-2031)
5.2.3 Global Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Application (2020-2031)
5.3 Global Nuclear Medicine & Radiopharmaceutic Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GE Healthcare
6.1.1 GE Healthcare Company Information
6.1.2 GE Healthcare Description and Business Overview
6.1.3 GE Healthcare Nuclear Medicine & Radiopharmaceutic Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GE Healthcare Nuclear Medicine & Radiopharmaceutic Product Portfolio
6.1.5 GE Healthcare Recent Developments/Updates
6.2 Bracco Imaging
6.2.1 Bracco Imaging Company Information
6.2.2 Bracco Imaging Description and Business Overview
6.2.3 Bracco Imaging Nuclear Medicine & Radiopharmaceutic Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bracco Imaging Nuclear Medicine & Radiopharmaceutic Product Portfolio
6.2.5 Bracco Imaging Recent Developments/Updates
6.3 Mallinckrodt
6.3.1 Mallinckrodt Company Information
6.3.2 Mallinckrodt Description and Business Overview
6.3.3 Mallinckrodt Nuclear Medicine & Radiopharmaceutic Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Mallinckrodt Nuclear Medicine & Radiopharmaceutic Product Portfolio
6.3.5 Mallinckrodt Recent Developments/Updates
6.4 Lantheus Medical Imaging
6.4.1 Lantheus Medical Imaging Company Information
6.4.2 Lantheus Medical Imaging Description and Business Overview
6.4.3 Lantheus Medical Imaging Nuclear Medicine & Radiopharmaceutic Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Lantheus Medical Imaging Nuclear Medicine & Radiopharmaceutic Product Portfolio
6.4.5 Lantheus Medical Imaging Recent Developments/Updates
6.5 Bayer
6.5.1 Bayer Company Information
6.5.2 Bayer Description and Business Overview
6.5.3 Bayer Nuclear Medicine & Radiopharmaceutic Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Bayer Nuclear Medicine & Radiopharmaceutic Product Portfolio
6.5.5 Bayer Recent Developments/Updates
6.6 Jubilant Pharma
6.6.1 Jubilant Pharma Company Information
6.6.2 Jubilant Pharma Description and Business Overview
6.6.3 Jubilant Pharma Nuclear Medicine & Radiopharmaceutic Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Jubilant Pharma Nuclear Medicine & Radiopharmaceutic Product Portfolio
6.6.5 Jubilant Pharma Recent Developments/Updates
6.7 Nordion
6.7.1 Nordion Company Information
6.7.2 Nordion Description and Business Overview
6.7.3 Nordion Nuclear Medicine & Radiopharmaceutic Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Nordion Nuclear Medicine & Radiopharmaceutic Product Portfolio
6.7.5 Nordion Recent Developments/Updates
6.8 Eli Lilly
6.8.1 Eli Lilly Company Information
6.8.2 Eli Lilly Description and Business Overview
6.8.3 Eli Lilly Nuclear Medicine & Radiopharmaceutic Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Eli Lilly Nuclear Medicine & Radiopharmaceutic Product Portfolio
6.8.5 Eli Lilly Recent Developments/Updates
6.9 SIEMENS
6.9.1 SIEMENS Company Information
6.9.2 SIEMENS Description and Business Overview
6.9.3 SIEMENS Nuclear Medicine & Radiopharmaceutic Sales, Revenue and Gross Margin (2020-2025)
6.9.4 SIEMENS Nuclear Medicine & Radiopharmaceutic Product Portfolio
6.9.5 SIEMENS Recent Developments/Updates
6.10 China Isotope & Radiation
6.10.1 China Isotope & Radiation Company Information
6.10.2 China Isotope & Radiation Description and Business Overview
6.10.3 China Isotope & Radiation Nuclear Medicine & Radiopharmaceutic Sales, Revenue and Gross Margin (2020-2025)
6.10.4 China Isotope & Radiation Nuclear Medicine & Radiopharmaceutic Product Portfolio
6.10.5 China Isotope & Radiation Recent Developments/Updates
6.11 Yantai Dongcheng Biochemicals
6.11.1 Yantai Dongcheng Biochemicals Company Information
6.11.2 Yantai Dongcheng Biochemicals Description and Business Overview
6.11.3 Yantai Dongcheng Biochemicals Nuclear Medicine & Radiopharmaceutic Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Yantai Dongcheng Biochemicals Nuclear Medicine & Radiopharmaceutic Product Portfolio
6.11.5 Yantai Dongcheng Biochemicals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nuclear Medicine & Radiopharmaceutic Industry Chain Analysis
7.2 Nuclear Medicine & Radiopharmaceutic Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nuclear Medicine & Radiopharmaceutic Production Mode & Process Analysis
7.4 Nuclear Medicine & Radiopharmaceutic Sales and Marketing
7.4.1 Nuclear Medicine & Radiopharmaceutic Sales Channels
7.4.2 Nuclear Medicine & Radiopharmaceutic Distributors
7.5 Nuclear Medicine & Radiopharmaceutic Customer Analysis
8 Nuclear Medicine & Radiopharmaceutic Market Dynamics
8.1 Nuclear Medicine & Radiopharmaceutic Industry Trends
8.2 Nuclear Medicine & Radiopharmaceutic Market Drivers
8.3 Nuclear Medicine & Radiopharmaceutic Market Challenges
8.4 Nuclear Medicine & Radiopharmaceutic Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
GE Healthcare
Bracco Imaging
Mallinckrodt plc
Lantheus Medical Imaging
Bayer
Jubilant Pharma
Nordion
Eli Lilly
Siemens AG
China Isotope & Radiation
Yantai Dongcheng Biochemicals
China Isotope & Radiation
List of Tables
 Table 1. Global Nuclear Medicine & Radiopharmaceutic Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Nuclear Medicine & Radiopharmaceutic Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Nuclear Medicine & Radiopharmaceutic Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Nuclear Medicine & Radiopharmaceutic Sales (Kiloton) of Key Manufacturers (2020-2025)
 Table 5. Global Nuclear Medicine & Radiopharmaceutic Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Nuclear Medicine & Radiopharmaceutic Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Nuclear Medicine & Radiopharmaceutic Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Nuclear Medicine & Radiopharmaceutic Average Price (US$/Ton) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Nuclear Medicine & Radiopharmaceutic, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Nuclear Medicine & Radiopharmaceutic, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Nuclear Medicine & Radiopharmaceutic, Product Type & Application
 Table 12. Global Key Manufacturers of Nuclear Medicine & Radiopharmaceutic, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Nuclear Medicine & Radiopharmaceutic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine & Radiopharmaceutic as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Nuclear Medicine & Radiopharmaceutic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Nuclear Medicine & Radiopharmaceutic Sales by Region (2020-2025) & (Kiloton)
 Table 18. Global Nuclear Medicine & Radiopharmaceutic Sales Market Share by Region (2020-2025)
 Table 19. Global Nuclear Medicine & Radiopharmaceutic Sales by Region (2026-2031) & (Kiloton)
 Table 20. Global Nuclear Medicine & Radiopharmaceutic Sales Market Share by Region (2026-2031)
 Table 21. Global Nuclear Medicine & Radiopharmaceutic Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Region (2020-2025)
 Table 23. Global Nuclear Medicine & Radiopharmaceutic Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Region (2026-2031)
 Table 25. North America Nuclear Medicine & Radiopharmaceutic Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Nuclear Medicine & Radiopharmaceutic Sales by Country (2020-2025) & (Kiloton)
 Table 27. North America Nuclear Medicine & Radiopharmaceutic Sales by Country (2026-2031) & (Kiloton)
 Table 28. North America Nuclear Medicine & Radiopharmaceutic Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Nuclear Medicine & Radiopharmaceutic Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Nuclear Medicine & Radiopharmaceutic Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Nuclear Medicine & Radiopharmaceutic Sales by Country (2020-2025) & (Kiloton)
 Table 32. Europe Nuclear Medicine & Radiopharmaceutic Sales by Country (2026-2031) & (Kiloton)
 Table 33. Europe Nuclear Medicine & Radiopharmaceutic Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Nuclear Medicine & Radiopharmaceutic Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Nuclear Medicine & Radiopharmaceutic Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Nuclear Medicine & Radiopharmaceutic Sales by Region (2020-2025) & (Kiloton)
 Table 37. Asia Pacific Nuclear Medicine & Radiopharmaceutic Sales by Region (2026-2031) & (Kiloton)
 Table 38. Asia Pacific Nuclear Medicine & Radiopharmaceutic Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Nuclear Medicine & Radiopharmaceutic Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Nuclear Medicine & Radiopharmaceutic Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Nuclear Medicine & Radiopharmaceutic Sales by Country (2020-2025) & (Kiloton)
 Table 42. Latin America Nuclear Medicine & Radiopharmaceutic Sales by Country (2026-2031) & (Kiloton)
 Table 43. Latin America Nuclear Medicine & Radiopharmaceutic Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Nuclear Medicine & Radiopharmaceutic Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Nuclear Medicine & Radiopharmaceutic Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Nuclear Medicine & Radiopharmaceutic Sales by Country (2020-2025) & (Kiloton)
 Table 47. Middle East and Africa Nuclear Medicine & Radiopharmaceutic Sales by Country (2026-2031) & (Kiloton)
 Table 48. Middle East and Africa Nuclear Medicine & Radiopharmaceutic Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Nuclear Medicine & Radiopharmaceutic Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Nuclear Medicine & Radiopharmaceutic Sales (Kiloton) by Type (2020-2025)
 Table 51. Global Nuclear Medicine & Radiopharmaceutic Sales (Kiloton) by Type (2026-2031)
 Table 52. Global Nuclear Medicine & Radiopharmaceutic Sales Market Share by Type (2020-2025)
 Table 53. Global Nuclear Medicine & Radiopharmaceutic Sales Market Share by Type (2026-2031)
 Table 54. Global Nuclear Medicine & Radiopharmaceutic Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Nuclear Medicine & Radiopharmaceutic Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Type (2020-2025)
 Table 57. Global Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Type (2026-2031)
 Table 58. Global Nuclear Medicine & Radiopharmaceutic Price (US$/Ton) by Type (2020-2025)
 Table 59. Global Nuclear Medicine & Radiopharmaceutic Price (US$/Ton) by Type (2026-2031)
 Table 60. Global Nuclear Medicine & Radiopharmaceutic Sales (Kiloton) by Application (2020-2025)
 Table 61. Global Nuclear Medicine & Radiopharmaceutic Sales (Kiloton) by Application (2026-2031)
 Table 62. Global Nuclear Medicine & Radiopharmaceutic Sales Market Share by Application (2020-2025)
 Table 63. Global Nuclear Medicine & Radiopharmaceutic Sales Market Share by Application (2026-2031)
 Table 64. Global Nuclear Medicine & Radiopharmaceutic Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Nuclear Medicine & Radiopharmaceutic Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Application (2020-2025)
 Table 67. Global Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Application (2026-2031)
 Table 68. Global Nuclear Medicine & Radiopharmaceutic Price (US$/Ton) by Application (2020-2025)
 Table 69. Global Nuclear Medicine & Radiopharmaceutic Price (US$/Ton) by Application (2026-2031)
 Table 70. GE Healthcare Company Information
 Table 71. GE Healthcare Description and Business Overview
 Table 72. GE Healthcare Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 73. GE Healthcare Nuclear Medicine & Radiopharmaceutic Product
 Table 74. GE Healthcare Recent Developments/Updates
 Table 75. Bracco Imaging Company Information
 Table 76. Bracco Imaging Description and Business Overview
 Table 77. Bracco Imaging Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 78. Bracco Imaging Nuclear Medicine & Radiopharmaceutic Product
 Table 79. Bracco Imaging Recent Developments/Updates
 Table 80. Mallinckrodt Company Information
 Table 81. Mallinckrodt Description and Business Overview
 Table 82. Mallinckrodt Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 83. Mallinckrodt Nuclear Medicine & Radiopharmaceutic Product
 Table 84. Mallinckrodt Recent Developments/Updates
 Table 85. Lantheus Medical Imaging Company Information
 Table 86. Lantheus Medical Imaging Description and Business Overview
 Table 87. Lantheus Medical Imaging Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 88. Lantheus Medical Imaging Nuclear Medicine & Radiopharmaceutic Product
 Table 89. Lantheus Medical Imaging Recent Developments/Updates
 Table 90. Bayer Company Information
 Table 91. Bayer Description and Business Overview
 Table 92. Bayer Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 93. Bayer Nuclear Medicine & Radiopharmaceutic Product
 Table 94. Bayer Recent Developments/Updates
 Table 95. Jubilant Pharma Company Information
 Table 96. Jubilant Pharma Description and Business Overview
 Table 97. Jubilant Pharma Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 98. Jubilant Pharma Nuclear Medicine & Radiopharmaceutic Product
 Table 99. Jubilant Pharma Recent Developments/Updates
 Table 100. Nordion Company Information
 Table 101. Nordion Description and Business Overview
 Table 102. Nordion Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 103. Nordion Nuclear Medicine & Radiopharmaceutic Product
 Table 104. Nordion Recent Developments/Updates
 Table 105. Eli Lilly Company Information
 Table 106. Eli Lilly Description and Business Overview
 Table 107. Eli Lilly Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 108. Eli Lilly Nuclear Medicine & Radiopharmaceutic Product
 Table 109. Eli Lilly Recent Developments/Updates
 Table 110. SIEMENS Company Information
 Table 111. SIEMENS Description and Business Overview
 Table 112. SIEMENS Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 113. SIEMENS Nuclear Medicine & Radiopharmaceutic Product
 Table 114. SIEMENS Recent Developments/Updates
 Table 115. China Isotope & Radiation Company Information
 Table 116. China Isotope & Radiation Description and Business Overview
 Table 117. China Isotope & Radiation Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 118. China Isotope & Radiation Nuclear Medicine & Radiopharmaceutic Product
 Table 119. China Isotope & Radiation Recent Developments/Updates
 Table 120. Yantai Dongcheng Biochemicals Company Information
 Table 121. Yantai Dongcheng Biochemicals Description and Business Overview
 Table 122. Yantai Dongcheng Biochemicals Nuclear Medicine & Radiopharmaceutic Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 123. Yantai Dongcheng Biochemicals Nuclear Medicine & Radiopharmaceutic Product
 Table 124. Yantai Dongcheng Biochemicals Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Nuclear Medicine & Radiopharmaceutic Distributors List
 Table 128. Nuclear Medicine & Radiopharmaceutic Customers List
 Table 129. Nuclear Medicine & Radiopharmaceutic Market Trends
 Table 130. Nuclear Medicine & Radiopharmaceutic Market Drivers
 Table 131. Nuclear Medicine & Radiopharmaceutic Market Challenges
 Table 132. Nuclear Medicine & Radiopharmaceutic Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Nuclear Medicine & Radiopharmaceutic
 Figure 2. Global Nuclear Medicine & Radiopharmaceutic Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Nuclear Medicine & Radiopharmaceutic Market Share by Type: 2024 & 2031
 Figure 4. Tc-99 Product Picture
 Figure 5. I-123/131 Product Picture
 Figure 6. In-111 Product Picture
 Figure 7. Xe-133 Product Picture
 Figure 8. Th-201 Product Picture
 Figure 9. Ga-67 Product Picture
 Figure 10. Other Product Picture
 Figure 11. Global Nuclear Medicine & Radiopharmaceutic Market Value by Application (2020-2031) & (US$ Million)
 Figure 12. Global Nuclear Medicine & Radiopharmaceutic Market Share by Application: 2024 & 2031
 Figure 13. Diagnostic
 Figure 14. Therapeutic
 Figure 15. Global Nuclear Medicine & Radiopharmaceutic Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Nuclear Medicine & Radiopharmaceutic Market Size (2020-2031) & (US$ Million)
 Figure 17. Global Nuclear Medicine & Radiopharmaceutic Sales (2020-2031) & (Kiloton)
 Figure 18. Global Nuclear Medicine & Radiopharmaceutic Average Price (US$/Ton) & (2020-2031)
 Figure 19. Nuclear Medicine & Radiopharmaceutic Report Years Considered
 Figure 20. Nuclear Medicine & Radiopharmaceutic Sales Share by Manufacturers in 2024
 Figure 21. Global Nuclear Medicine & Radiopharmaceutic Revenue Share by Manufacturers in 2024
 Figure 22. Global 5 and 10 Largest Nuclear Medicine & Radiopharmaceutic Players: Market Share by Revenue in Nuclear Medicine & Radiopharmaceutic in 2024
 Figure 23. Nuclear Medicine & Radiopharmaceutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Global Nuclear Medicine & Radiopharmaceutic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 25. North America Nuclear Medicine & Radiopharmaceutic Sales Market Share by Country (2020-2031)
 Figure 26. North America Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Country (2020-2031)
 Figure 27. U.S. Nuclear Medicine & Radiopharmaceutic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Canada Nuclear Medicine & Radiopharmaceutic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Europe Nuclear Medicine & Radiopharmaceutic Sales Market Share by Country (2020-2031)
 Figure 30. Europe Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Country (2020-2031)
 Figure 31. Germany Nuclear Medicine & Radiopharmaceutic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. France Nuclear Medicine & Radiopharmaceutic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. U.K. Nuclear Medicine & Radiopharmaceutic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Italy Nuclear Medicine & Radiopharmaceutic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Russia Nuclear Medicine & Radiopharmaceutic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific Nuclear Medicine & Radiopharmaceutic Sales Market Share by Region (2020-2031)
 Figure 37. Asia Pacific Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Region (2020-2031)
 Figure 38. China Nuclear Medicine & Radiopharmaceutic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Japan Nuclear Medicine & Radiopharmaceutic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. South Korea Nuclear Medicine & Radiopharmaceutic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. India Nuclear Medicine & Radiopharmaceutic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Australia Nuclear Medicine & Radiopharmaceutic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. China Taiwan Nuclear Medicine & Radiopharmaceutic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Indonesia Nuclear Medicine & Radiopharmaceutic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Thailand Nuclear Medicine & Radiopharmaceutic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Malaysia Nuclear Medicine & Radiopharmaceutic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Nuclear Medicine & Radiopharmaceutic Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Nuclear Medicine & Radiopharmaceutic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Nuclear Medicine & Radiopharmaceutic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Nuclear Medicine & Radiopharmaceutic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Nuclear Medicine & Radiopharmaceutic Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Nuclear Medicine & Radiopharmaceutic Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Nuclear Medicine & Radiopharmaceutic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Nuclear Medicine & Radiopharmaceutic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. UAE Nuclear Medicine & Radiopharmaceutic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Nuclear Medicine & Radiopharmaceutic by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Nuclear Medicine & Radiopharmaceutic by Type (2020-2031)
 Figure 59. Global Nuclear Medicine & Radiopharmaceutic Price (US$/Ton) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Nuclear Medicine & Radiopharmaceutic by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Nuclear Medicine & Radiopharmaceutic by Application (2020-2031)
 Figure 62. Global Nuclear Medicine & Radiopharmaceutic Price (US$/Ton) by Application (2020-2031)
 Figure 63. Nuclear Medicine & Radiopharmaceutic Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Isotopes for Nuclear Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Radionuclide Therapy Equipment Market Insights Forecast to 2030
Nuclear Medicine Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
0 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nuclear Molecular Imaging System Market Research Report 2025
Medical Imaging Information Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Nuclear Medicine Software System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cardiovascular Medical Device and Diagnostics Trials Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Oncology Precision Medicine Market
Global Radiopharmacy Equipment Market Research Report 2025
Used Medical Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Medical Diagnostic Radiology Display Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Healthcare IT Diagnostic Imaging Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global All in one Imaging System Market Research Report 2025
Global Radiation Therapy Devices Market Research Report 2025
Real World Evidence in Healthcare Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global 0 Market Research Report 2024
Global 0 Market Research Report 2024
Medical Guidewires Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cardiovascular Clinical Imaging Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Advanced Fuel Cells Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14S7936
Tue Sep 16 00:00:00 UTC 2025

Add to Cart

Global Maximum Power Point Tracking Charge Controllers Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22D7379
Tue Sep 16 00:00:00 UTC 2025

Add to Cart

Global DIN Rail Buffer Modules Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-23Q8548
Tue Sep 16 00:00:00 UTC 2025

Add to Cart

Global Smart Tracker Battery Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y8082
Tue Sep 16 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions